Financial tracks

H.C. Wainwright hired Ching-Yi Lin as a managing director in equity research and senior biotechnology analyst. She was a senior research associate at Stifel covering the pharmaceutical sector.

Sofinnova Ventures hired Daniel Welch as an executive partner. Most recently, Welch was chairman, president and CEO of InterMune Inc., which was acquired by Roche (SIX:ROG; OTCQX:RHHBY) last year. Welch is on the board of Hyperion Therapeutics Inc. (NASDAQ:HPTX) and Seattle Genetics Inc. (NASDAQ:SGEN). ...